What Compumedics does

Compumedics Limited (ASX: CMP) is a Melbourne-based medical device company founded in 1987 that designs, manufactures, and commercializes diagnostic technology across three core verticals: sleep diagnostics, neurology diagnostics, and brain research. The company operates a hardware-plus-software platform built around proprietary amplifiers and signal acquisition systems (including the Orion LifeSpan MEG with patented DROS SQUID sensors, the Grael 4K PSG:EEG amplifier, Somté ambulatory recorders, Okti portable EEG, and the Somfit wearable sensor), layered with a software stack (Profusion Sleep/EEG, CURRY multimodal neuroimaging suite, and Profusion neXus 360 cloud-based lab management). The portfolio is FDA-cleared, CE-marked, and TGA-cleared for clinical use and is sold via direct enterprise field sales through wholly-owned offices in Australia, the United States, Germany, and France, complemented by distributor arrangements in China and other regions.

The company's revenue model is anchored on capital equipment sales (large systems such as the Orion LifeSpan MEG sell at approximately AUD 4.2 million per unit), recurring software subscriptions and cloud hosting via neXus 360, consumables and electrode/supply sales, and professional services for pharmaceutical clinical trials. Customer segmentation is vertical, with primary end markets being hospital sleep labs and neurology departments, university and research institutions conducting brain imaging research, pharmaceutical sponsors and CROs using EEG endpoints in trials, and emerging applications in sports/military traumatic brain injury screening. The company invests over 15% of revenue in R&D and maintains a 30-year technical collaboration with the Korean Research Institute of Standards and Science (KRISS) underpinning its MEG franchise.

Compumedics is publicly listed on the ASX since 2000, has a global workforce of 101–250 employees, and operates through subsidiaries including Compumedics USA Inc., Compumedics Germany GmbH (DWL), Compumedics Europe GmbH (Neuroscan), and Compumedics France SAS. Leadership is founder-led, with David Burton as Founder, CEO, and Executive Chairman. As of October 2025 the company requested a trading halt pending a capital raising announcement, indicating active use of public equity markets to fund expansion, particularly its China MEG pipeline where it has reported approximately AUD 30 million in contracted MEG orders across six systems.

Name

Compumedics

Legal name

Compumedics Limited

Website

https://compumedics.com.au

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

101–250 employees

Short description

Compumedics (ASX: CMP) designs, manufactures, and commercializes medical diagnostic devices and software for sleep, neurology, and brain research, serving hospitals, research institutions, pharmaceutical companies, and emerging sports/military TBI markets through direct sales offices across Australia, the United States, Germany, and France.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industries

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Sleep Tech Wearables (CRACAIAG), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)

Keywords

• Sleep diagnostic devices
• EEG monitoring systems
• Magnetoencephalography equipment
• Polysomnography amplifiers
• Neuroimaging software

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Hardware Sales: Sale of diagnostic medical devices including MEG systems, PSG amplifiers, EEG amplifiers, sleep recorders, and accessories. Major orders include MEG systems at approximately AUD $4.2 million per unit. Products sold directly and through distributors.
2. Software Licensing and Subscriptions: Software products including Profusion Sleep, Profusion EEG, Profusion neXus 360, CURRY software. Cloud-based services through neXus 360 hosting. Version updates and support services.
3. Supplies and Consumables: Sale of supplies including electrodes, electrode caps, sensors, accessories, and consumable products for diagnostic systems.
4. Pharmaceutical Clinical Trial Support: Comprehensive support services for pharmaceutical clinical trials including EEG as endpoint measurements, remote monitoring, data management, and regulatory compliance support.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Compumedics designs, manufactures, and commercializes medical diagnostic technology for sleep disorders, neurology, and brain research. Its hardware portfolio includes magnetoencephalography (MEG) systems (Orion LifeSpan), polysomnography (PSG) and EEG amplifiers (Grael 4K, Somté, Siesta 802, Okti, Neuvo), home sleep testing devices (Falcon HST), wearable sensors (Somfit), ambulatory video-EEG monitors (ONsight), and transcranial Doppler systems. Its software portfolio spans the Profusion sleep/EEG analysis suite, the Profusion neXus 360 cloud-based lab management platform, and the CURRY multimodal neuroimaging suite.

Product overview

Compumedics designs and manufactures medical technology for sleep diagnostics, neurology diagnostics, and brain research. The company operates a platform-plus-modules architecture centered on proprietary amplifiers and software. The hardware portfolio includes MEG systems (Orion LifeSpan), PSG/EEG amplifiers (Grael 4K, Somté, Siesta 802, Okti), and specialized devices (Falcon HST for home sleep testing, Somfit wearable sensor, ONsight video-EEG, DWL TBI detector). The software platform comprises Profusion EEG/Sleep, Profusion neXus 360 lab management, and CURRY neuroimaging suite. Key sub-brands include Compumedics Neuroscan (research/brain research) and Compumedics DWL (transcranial Doppler). The company has invested over 15% of revenues in R&D and holds multiple regulatory clearances including FDA, CE Mark, and TGA. Founded in 1987, Compumedics is listed on the Australian Securities Exchange (ASX: CMP) with global operations across Australia, USA, Germany, and France.

Differentiator

Problem solved

Functional benefit

Brands

• Somfit: Wearable device for collecting patients' physiological data, primarily for sleep disorder diagnosis
• Grael
• Somté
• Profusion
• CURRY
• Orion LifeSpan
• Falcon HST
• Neuvo
• Okti
• ONsight A.V.S.

Products and services

• Orion LifeSpan MEG Magnetoencephalography (MEG) brain functional imaging system with patented DROS SQUID sensors, dual-helmet operation for adult and pediatric populations, 100% helium recycling enabling 24/7 continuous operation, and integration with CURRY neuroimaging software. Supports high-density EEG up to 256 channels. Sold primarily to research institutions at approximately AUD 4.2 million per unit.
• Grael 4K PSG:EEG World's first 4K High Definition dual-platform PSG:EEG amplifier with 24-bit resolution, DC-coupled inputs, integrated Power over Ethernet, and wireless connectivity for sleep and neurological diagnostics. Used in hospitals and sleep clinics for combined sleep and EEG studies.
• Grael PSG
• Grael 4K-EEG
• Grael LT EEG System
• Neuvo 64-512 Channel LTM EEG
• Somté PSG
• Somté
• Siesta 802
• Okti First high-definition portable EEG amplifier with interchangeable modules (32, 64, 128 channels), wireless enterprise WiFi connectivity, hot-swappable batteries, and patented electrode illumination indicators for rapid patient setup.
• Falcon HST Home sleep testing device with unmatched simplicity and clinical precision, featuring cloud/local deployment options, reusable/disposable sensor kits, and integrated ProDigi scoring via Nexus 360.
• Somfit / Somfit Pro
• ONsight A.V.S.
• DWL Traumatic Brain Injury (TBI) Device
• CURRY Neuroimaging Suite
• Profusion EEG Software Clinical EEG software with Microsoft Ribbon interface, supporting up to 45 days continuous recording, high sample rates (up to 10kHz), EDF+ export, and video-EEG synchronization for epilepsy monitoring.
• Profusion Sleep Software Sleep analysis software suite with AASM V2 compliance, modern user interface, respiratory band phase analysis, and comprehensive report generation for sleep laboratories.
• Profusion neXus 360
• Transcranial Doppler Sonography (TCD) - Compumedics DWL Transcranial Doppler ultrasound systems for cerebral blood flow monitoring using fully-Doppler sonography with M-Mode, provided through the Compumedics DWL subsidiary based in Singen, Germany.
• Pharmaceutical Clinical Trials & Research Services

Quantifiable outcome

• 100% helium recycling enables 24/7 continuous MEG operation with no downtime
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Beijing FistarcoreChannel Partner/ Reseller/ Distributor · 29 January 2026Beijing Fistar serves as the distributor for Compumedics MEG systems in China, facilitating sales to Chinese research institutions including Shandong Normal University. The partnership enabled the AUD 4.2 million Orion LifeSpan MEG order.
• Korean Research Institute of Standards and Science (KRISS)coreStrategic or Co-development Partner30-year collaboration with KRISS MEG team led by Dr. Yong-Ho Lee to develop the Orion LifeSpan MEG system with patented DROS SQUID sensor technology.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Natus Medical: Natus Medical is one of the closest direct competitors to Compumedics, offering a broad portfolio of neurodiagnostic (EEG, LTM, ICU monitoring) and sleep-diagnostic (PSG, HST) hardware and software used by the same hospital and clinical customers.
• MEGIN (formerly Elekta MEG): MEGIN is the primary global competitor in magnetoencephalography (MEG) systems, the same niche occupied by Compumedics' Orion LifeSpan platform, serving brain-research and clinical neuroscience customers.
• Cadwell Industries: Cadwell designs and sells EEG, PSG, and intraoperative neuro-monitoring systems to hospitals and sleep labs, directly overlapping Compumedics' neurology and sleep diagnostics amplifier portfolios.
• Nox Medical: Nox Medical specialises in PSG and home sleep testing devices and software (Noxturnal), competing head-to-head with Compumedics' Grael, Somté and Falcon HST products in sleep labs and research settings.

Broad incumbents

• Nihon Kohden: Nihon Kohden is a larger, established player in clinical EEG, patient monitoring and polysomnography, with global distribution that overlaps Compumedics' clinical neurodiagnostic and PSG amplifier businesses.
• Philips (Sleep & Respiratory): Philips offers a broad sleep-diagnostics and respiratory-care portfolio (including Alice PSG) targeting the same hospital and sleep-centre customers as Compumedics, but as part of a much wider medtech franchise.
• ResMed: ResMed is a global leader in sleep apnea diagnosis and therapy, operating adjacent home sleep testing and consumer sleep health offerings that overlap Compumedics' Somfit and Falcon HST businesses.
• Medtronic: Medtronic is named alongside Compumedics in third-party brain-monitoring market research and competes broadly in neurology and brain diagnostics through its larger hospital channel and capital equipment business.

Emerging players

• Wave Neuroscience: Wave Neuroscience applies MEG-based brain-activity analysis in clinical and research settings, partially overlapping Compumedics' MEG and neuroimaging analysis offering but with a more concentrated therapy/treatment orientation.

Others

• Persyst Development Corporation: Persyst provides EEG analysis and seizure-detection software that Compumedics resells/distributes alongside its Profusion EEG platform; not a direct competitor but an ecosystem partner in the same neurology diagnostics workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/compumedics
• Facebookfacebook.com/compumedics-107758744576
• LinkedInlinkedin.com/company/840352

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Compumedics